SEC Form 4 · accession 0001127602-18-009770
GILEAD SCIENCES, INC. · GILD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robin L Washington
Officer — EVP, CFO
Period of report
Feb 21, 2018
Accepted (ET)
Mar 2, 2018 · 6:47 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000882095
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 21, 2018 | G | 340 | $0.00 | D | 23,749 | D | |
| Common StockF1 | Feb 21, 2018 | G | 340 | $0.00 | A | 103,817 | I | By Trust |
| Common StockF1 | Feb 28, 2018 | G | 6,588 | $0.00 | D | 17,161 | D | |
| Common StockF1 | Feb 28, 2018 | G | 6,588 | $0.00 | A | 110,405 | I | By Trust |
| Common StockF3 | Feb 28, 2018 | S | 5,000 | $80.3132 | D | 105,405 | I | By Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares gifted to family trust.
- F2Open market sale from family trust shares
- F3Sale prices reported for the transactions reported here range from $80.311 to $80.33. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.